Overall, for treatment of hyperglycaemia, metformin remains the agent of choice in most people with diabetes, based on its glucose-lowering efficacy, minimal risk of hypoglycaemia, lack of weight increase and affordability
Use our comparison tool to filter by insurance acceptance, medication type, price, and telehealth availability.
Patients manage their orders, consultations, and shipping details through the Direct Meds patient portal, which functions as a centralized hub for the entire care journey
In December 2014, the Food and Drug Administration (FDA) approved liraglutide for weight loss, and semaglutide was approved for diabetes in 2017 and obesity in 2021, opening a new era of obesity treatment
We make it easy to get your semaglutide prescription at the lowest price possible